CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Pharma
Original article

Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Neutral
AI Analysis

Summary

Nektar Therapeutics announced the grant of non-qualified stock options to purchase 36,000 shares as inducement grants under NASDAQ Listing Rule 5635(c)(4) on July 20, 2026.

Importance:1/10
Sentiment:
0.00
stock optionsinducement grantscompensationNASDAQ rule
Related Companies

Read the original article

Published by PR Newswire Pharma on July 24, 2026 8:15 PM

Read Original